Hacker Newsnew | past | comments | ask | show | jobs | submit | more ampdepolymerase's commentslogin

No, no, no. Explanation is inaccurate. The central dogma is the central dogma because information flow is primarily one way (yes there are exceptions i.e. epigenetics but primary information flow is from DNA to protein) and this is the fundamental tenet underpinning our current understanding of biology.

> A multicellular organism gametes divide only a handfull of times per generation.

That's what recombination is for during sexual reproduction.

> It does not contain informtion how to assemble the molecular machines from the proteins, or how "to be alive" in general.

Unless you subscribe to the creationist or Larmarckian schools of thought, this is flat out wrong. DNA polymerase and similar analogues like reverse transcriptase do not exist in a vacuum. There are entire branches of evolutionary biology dedicated to studying their formation. The main transcription proteins, helicase, polymerase, and ribosomes can all be assembled from the basic proteins they themselves transcribe. (Incidentally figuring out the ultimate structure that a protein chain assembles into is what AlphaFold does, bioinformatics and ML's crowning jewel)

> There is heritable information outside of DNA, that is epigenetic in its nature.

When biologists refer to epigenetics, they mean information carriage that's not strictly tied to the nucleotides. This doesn't meant DNA isn't involved. Most epigenetics I can think of off the top of my head all involve the DNA transcription mechanism in some way.


> This is still relevant to his concern, but from the other end. They might be making the labor artificially scarce to increase pay.

This is very much true. I find that a lot of people in tech seem to put healthcare on a pedestal and believe that the professionalisation and gatekeeping of the industry create a better outcome than other engineering fields. This is very much untrue, the healthcare field is in need of massive disruption and lobbying to increase labor supply. You are being downvoted because a lot of tech people here hate to imagine that healthcare at the highest level is still subject to market forces like everything else. Medical training is being severely gatekept and hindered via the current apprenticeship/residency system. After all, we call the worst medical student, doctor. If you want to improve healthcare, tie medical school admission to the MCAT score, and only the MCAT score. You are not going to get better doctors just because candidates spend their summers building houses in some impoverished third world country.


I live near Boston which is known for its medical centers, so this might skew things somewhat, but it seems like every graduate I know is going into medicine of some form (surgery, anesthesia, nursing, surgical tech, hospice, etc. etc.)

I heard consistently that residency slots are extremely competitive and a lot of qualified candidates get passed over. The more I learn about the process the more insane it seems.

From the student perspective you go from paying to work one day and spending most your time working cases with zero relevance to your actual specialty, to raking in several hundred thousand a year.

It also seems like hospital systems seem to spend more than half their capacity either dealing with patients that don’t need to be there but there’s literally no place to send them, or patients that are too far gone and untreatable but there’s literally no place to send them.

Healthcare is like a Gordian knot of terrible policies cemented into place by trillions of dollars of government spending.


We turn away beyond capable people, it’s just that we have decided to drastically reduce the number of doctors per capita by artificially limiting the number of medical schools.


It's not the number of medical schools that is the issue, it's the amount of residency spots available after graduating med school (in the us).


Note FDA rules require them to retain the data for a few years.


Any idea what the reasoning behind these FDA rules is?


European here: I can't wait to use my gdpr superpowers to cause an expectation violation there.


Doesn't the GDPR have an exception for data required for legal reasons?

Anyway, an US lab won't care about it.


It has some cut outs, but not as many as you would think.

The US lab is marketing to EU customers. They will care about GDPR (heck, they even claim to be compliant on their website).


There is a bigger iceberg lurking around. Look up the people who control medical school accreditation and funding. They have more blood on hands than many other industries put together. Medical innovation has been slowed down by magnitudes because of their gatekeeping.


It’s not just medical schools but the entire pipeline from there into professional accreditation by limiting residency programs working with Congress to cap them as part of Medicare legislation / funding. It’s only recently that the AMA agreed to lift the spots.

There’s a lot of reasons that the US has to keep importing in doctors and nurses at lower end of market rates while our medical costs as a system soar into unaffordability and bleed into increasing costs for every single other private sector possible. If Big Oil did this they’d be practicing racketeering and price gouging in the open.


Not just funding and accreditation, but admissions as well.

https://en.wikipedia.org/wiki/Jung_v._Association_of_America...


More specifically pseudo science not guided by empiricism. The line between science and pseudo science is very thin. Scientific theories are often incorrect, especially in life science, but we refine upon them based in empirical and observed data.


You are right, but when results are falsified because of political expedience, that refining process will be subverted or discarded altogether.


Voit looks gimmicky. Uri Alon's treatment (An Introduction to Systems Biology) is much better.


There is a bottleneck in the number of MD positions. Without the MD title, your typical life science researcher cannot easily carry out medical research. Medical education and training has a scale problem.


It's possible to get closely involved with this kind of research with just a PhD, but there are all kinds of issues with that career path too.


To conduct good clinical research, I think you need to understand the constraints of clinical practice. It's not only a matter of holding the title, but more of practical experience.


You do need someone with the clinical experience to understand the questions that need asking and to confirm the trends and suspicions seen in clinical practice, but clinical academics are expensive, and also terrible at stats and good research practice. I think the right mix of both is important.


I won't put too much stock in unglazed clay cooking ware.


The best C and C++ package manager I have used is Xmake/Xrepo. They support all the major package repositories out of the box including Vcpkg and Conan.

https://github.com/xmake-io/xmake#supported-package-reposito...


xmake is a great tool with complexity. clib's key design goal is simplicity, use the best fit one for next project.


Simplicity is vastly overrated.


This. Simplicity should not be confused with lack of necessary features for bigger projects that hopefully yours will be.


X is vastly overrated.



Human trials for drugs is the expensive part. If the situation is urgent, look into compassionate use and right to try. If you have time, the fastest way to get it to production is to have the trials done in a lower cost country. At the end of the day if you control the experiment and manufacturing pipeline, then you can make a develop a drug for a much lower price. You absolutely cannot cut corners in the experimental and engineering stage even if you do it in a more compliant regulatory regime.


Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: